那FDA拒批的背后，是否藏着一些我们未曾了解的深层原因呢？根据FDA提出的要求，这次的审查着眼于一项涉及132名患者的后期临床试验，旨在测试这个药物如何减轻眼部不适症状。结果是什么呢？辣眼睛！最终试验结果未载期待，反而引发了FDA的关注。这次事件不仅让投资者感到失望，也把Aldeyra的未来再次推向了未知的深渊。

As director of the FDA's Center for Biologics Evaluation and Research, Marks has publicly supported programs that expedited ...

WASHINGTON (AP) — Weeks after ordering Food and Drug Administration employees back into the office, the agency is reversing ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...

Biotech stocks had a bad week after turmoil at the FDA, continuing a long period of underperformance after the pandemic. Many ...

A federal commission is calling for $15 billion in new financing to reinforce U.S. biotech leadership amid competition from ...

On The Readout LOUD podcast, STAT reporters talk about new FDA commissioner Marty Makary's first week amid a swirl of layoffs ...

Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.

FDA Chief Medical Officer Hilary Marston, M.D., is leaving her position at the agency.  | The FDA’s Chief Medical Officer ...

The biopharmaceutical company has announced the receipt of final approval from the United States Food and Drug Administration (USFDA) for marketing its Teriflunomide Tablets in various strengths.